House of Lords Business
Show full summary

Lord Rogan to ask His Majesty's Government what discussions they have had, or are intending to have, with (1) Takeda Pharmaceuticals, and (2) EGFR Positive UK, following the withdrawal of the drug Mobocertinib from the UK market.  HL10582

Question HL10582: tabled on 16 October 2023 and due for answer by 30 October 2023

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Rogan to ask His Majesty's Government what discussions they have had, or are intending to have, with (1) Takeda Pharmaceuticals, and (2) EGFR Positive UK, following the withdrawal of the drug Mobocertinib from the UK market.  HL10582
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Rogan
Ulster Unionist Party
Life peer